Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA.
J Stroke Cerebrovasc Dis. 2022 Dec;31(12):106840. doi: 10.1016/j.jstrokecerebrovasdis.2022.106840. Epub 2022 Oct 23.
Direct carotid-cavernous fistulas are high-flow abnormal connections between the carotid artery and cavernous sinus, which are associated with significant morbidity and mortality if left untreated. In addition to endovascular coil embolization, there is an evolving role for alternative stand-alone or adjunctive treatment approaches. We describe a case of flow diversion as an adjunctive treatment approach in a treatment-resistant direct carotid-cavernous fistula and review the literature on the use of flow diversion in this clinical context.
We describe the clinical course, imaging findings, and outcome of a patient who developed a traumatic carotid-cavernous fistula requiring multiple interventions. We also performed an updated literature review of all published cases of flow diversion use in the treatment of direct CCFs.
Our patient achieved angiographic cure and significant improvement in symptoms at 6-month follow-up. A total of 53 cases of flow diversion use in direct carotid-cavernous fistulas were identified from a literature search. In one third of cases, flow diversion was used as a stand-alone treatment modality. Angiographic resolution was achieved in 90% of cases at a median follow-up duration of 6 months. One half of reported cases had complete resolution of symptoms and a further third noted clinical improvement in at least some of their symptoms.
There is an emerging role for flow diversion as a safe and effective stand-alone or adjunctive treatment option for direct carotid-cavernous fistulas. Our case further supports a role for flow diversion in treatment-resistant fistulas with high-risk features. As treatment approaches continue to evolve, prospective, randomized data will be needed to establish the role of flow divertors in the hierarchy of available treatments for carotid-cavernous fistulas.
直接颈动脉-海绵窦瘘是颈动脉和海绵窦之间异常的高流量连接,如果不治疗,会导致很高的发病率和死亡率。除了血管内线圈栓塞,还有一些替代的独立或辅助治疗方法在不断发展。我们描述了一例作为辅助治疗方法的血流转向在治疗抵抗性直接颈动脉-海绵窦瘘中的应用,并复习了在这种临床情况下使用血流转向的文献。
我们描述了一例患者的临床过程、影像学发现和结果,该患者发生了创伤性颈动脉-海绵窦瘘,需要多次干预。我们还对所有已发表的使用血流转向治疗直接 CCF 的病例进行了更新的文献复习。
我们的患者在 6 个月的随访时实现了血管造影治愈和症状的显著改善。从文献检索中总共确定了 53 例直接颈动脉-海绵窦瘘使用血流转向的病例。在三分之一的病例中,血流转向被用作单一治疗模式。在中位随访 6 个月时,90%的病例达到了血管造影的缓解。报告的病例中有一半完全缓解了症状,另有三分之一的病例至少在某些症状上有临床改善。
血流转向作为一种安全有效的独立或辅助治疗方法,在直接颈动脉-海绵窦瘘中具有新兴的作用。我们的病例进一步支持了血流转向在具有高风险特征的治疗抵抗性瘘中的作用。随着治疗方法的不断发展,需要前瞻性、随机数据来确定血流转向器在颈动脉-海绵窦瘘的现有治疗方法中的作用。